img

Global Human Rotavirus Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Rotavirus Vaccine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Human Rotavirus Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Rotavirus Vaccine market is projected to reach US$ 10360 million in 2034, increasing from US$ 6753.8 million in 2022, with the CAGR of 6.2% during the period of 2024 to 2034. Demand from Hospitals & Clinics and Academic And Research are the major drivers for the industry.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Rotavirus Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bharat Biotech
Merck
GlaxoSmithKline
Segment by Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others

Segment by Application


Hospitals & Clinics
Academic And Research
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Human Rotavirus Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Rotavirus Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Rotavirus Vaccine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Human Rotavirus Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Rotavirus Vaccine introduction, etc. Human Rotavirus Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Human Rotavirus Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Human Rotavirus Vaccine Market Overview
1.1 Human Rotavirus Vaccine Product Overview
1.2 Human Rotavirus Vaccine Market Segment by Type
1.2.1 Rotarix
1.2.2 RotaTeq
1.2.3 Rotavac
1.2.4 Rotavin-M1
1.2.5 Lanzhou lamb
1.2.6 Others
1.3 Global Human Rotavirus Vaccine Market Size by Type
1.3.1 Global Human Rotavirus Vaccine Market Size Overview by Type (2024-2034)
1.3.2 Global Human Rotavirus Vaccine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Human Rotavirus Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Rotavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Human Rotavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Human Rotavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Human Rotavirus Vaccine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Human Rotavirus Vaccine Sales Breakdown by Type (2024-2024)
2 Global Human Rotavirus Vaccine Market Competition by Company
2.1 Global Top Players by Human Rotavirus Vaccine Sales (2024-2024)
2.2 Global Top Players by Human Rotavirus Vaccine Revenue (2024-2024)
2.3 Global Top Players by Human Rotavirus Vaccine Price (2024-2024)
2.4 Global Top Manufacturers Human Rotavirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Rotavirus Vaccine Market Competitive Situation and Trends
2.5.1 Human Rotavirus Vaccine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Rotavirus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rotavirus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Human Rotavirus Vaccine Market
2.8 Key Manufacturers Human Rotavirus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Rotavirus Vaccine Status and Outlook by Region
3.1 Global Human Rotavirus Vaccine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Human Rotavirus Vaccine Historic Market Size by Region
3.2.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2024-2024)
3.2.2 Global Human Rotavirus Vaccine Sales in Value by Region (2024-2024)
3.2.3 Global Human Rotavirus Vaccine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Human Rotavirus Vaccine Forecasted Market Size by Region
3.3.1 Global Human Rotavirus Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Human Rotavirus Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Human Rotavirus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Rotavirus Vaccine by Application
4.1 Human Rotavirus Vaccine Market Segment by Application
4.1.1 Hospitals & Clinics
4.1.2 Academic And Research
4.1.3 Others
4.2 Global Human Rotavirus Vaccine Market Size by Application
4.2.1 Global Human Rotavirus Vaccine Market Size Overview by Application (2024-2034)
4.2.2 Global Human Rotavirus Vaccine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Human Rotavirus Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Rotavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Human Rotavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Human Rotavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Human Rotavirus Vaccine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Human Rotavirus Vaccine Sales Breakdown by Application (2024-2024)
5 North America Human Rotavirus Vaccine by Country
5.1 North America Human Rotavirus Vaccine Historic Market Size by Country
5.1.1 North America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Human Rotavirus Vaccine Sales in Volume by Country (2024-2024)
5.1.3 North America Human Rotavirus Vaccine Sales in Value by Country (2024-2024)
5.2 North America Human Rotavirus Vaccine Forecasted Market Size by Country
5.2.1 North America Human Rotavirus Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Human Rotavirus Vaccine Sales in Value by Country (2024-2034)
6 Europe Human Rotavirus Vaccine by Country
6.1 Europe Human Rotavirus Vaccine Historic Market Size by Country
6.1.1 Europe Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Human Rotavirus Vaccine Sales in Volume by Country (2024-2024)
6.1.3 Europe Human Rotavirus Vaccine Sales in Value by Country (2024-2024)
6.2 Europe Human Rotavirus Vaccine Forecasted Market Size by Country
6.2.1 Europe Human Rotavirus Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Rotavirus Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Rotavirus Vaccine by Region
7.1 Asia-Pacific Human Rotavirus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Rotavirus Vaccine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Human Rotavirus Vaccine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Human Rotavirus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Rotavirus Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Rotavirus Vaccine Sales in Value by Region (2024-2034)
8 Latin America Human Rotavirus Vaccine by Country
8.1 Latin America Human Rotavirus Vaccine Historic Market Size by Country
8.1.1 Latin America Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Human Rotavirus Vaccine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Human Rotavirus Vaccine Sales in Value by Country (2024-2024)
8.2 Latin America Human Rotavirus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Human Rotavirus Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Rotavirus Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Rotavirus Vaccine by Country
9.1 Middle East and Africa Human Rotavirus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Human Rotavirus Vaccine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Rotavirus Vaccine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Human Rotavirus Vaccine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Human Rotavirus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Rotavirus Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Rotavirus Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bharat Biotech
10.1.1 Bharat Biotech Company Information
10.1.2 Bharat Biotech Introduction and Business Overview
10.1.3 Bharat Biotech Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bharat Biotech Human Rotavirus Vaccine Products Offered
10.1.5 Bharat Biotech Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Merck Human Rotavirus Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Human Rotavirus Vaccine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GlaxoSmithKline Human Rotavirus Vaccine Products Offered
10.3.5 GlaxoSmithKline Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Rotavirus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Rotavirus Vaccine Industrial Chain Analysis
11.4 Human Rotavirus Vaccine Market Dynamics
11.4.1 Human Rotavirus Vaccine Industry Trends
11.4.2 Human Rotavirus Vaccine Market Drivers
11.4.3 Human Rotavirus Vaccine Market Challenges
11.4.4 Human Rotavirus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Rotavirus Vaccine Distributors
12.3 Human Rotavirus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Rotarix
Table 2. Major Company of RotaTeq
Table 3. Major Company of Rotavac
Table 4. Major Company of Rotavin-M1
Table 5. Major Company of Lanzhou lamb
Table 6. Major Company of Others
Table 7. Global Human Rotavirus Vaccine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 8. Global Human Rotavirus Vaccine Sales by Type (2024-2024) & (K Units)
Table 9. Global Human Rotavirus Vaccine Sales Market Share in Volume by Type (2024-2024)
Table 10. Global Human Rotavirus Vaccine Sales by Type (2024-2024) & (US& Million)
Table 11. Global Human Rotavirus Vaccine Market Share in Value by Type (2024-2024)
Table 12. Global Human Rotavirus Vaccine Price by Type (2024-2024) & (USD/Unit)
Table 13. Global Human Rotavirus Vaccine Sales by Type (2024-2034) & (K Units)
Table 14. Global Human Rotavirus Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Human Rotavirus Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Human Rotavirus Vaccine Sales Market Share in Value by Type (2024-2034)
Table 17. Global Human Rotavirus Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 18. North America Human Rotavirus Vaccine Sales by Type (2024-2024) & (K Units)
Table 19. North America Human Rotavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 20. Europe Human Rotavirus Vaccine Sales (K Units) by Type (2024-2024)
Table 21. Europe Human Rotavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 22. Asia-Pacific Human Rotavirus Vaccine Sales (K Units) by Type (2024-2024)
Table 23. Asia-Pacific Human Rotavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 24. Latin America Human Rotavirus Vaccine Sales (K Units) by Type (2024-2024)
Table 25. Latin America Human Rotavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 26. Middle East and Africa Human Rotavirus Vaccine Sales (K Units) by Type (2024-2024)
Table 27. Middle East and Africa Human Rotavirus Vaccine Sales by Type (2024-2024) & (US$ Million)
Table 28. Global Human Rotavirus Vaccine Sales by Company (2024-2024) & (K Units)
Table 29. Global Human Rotavirus Vaccine Sales Share by Company (2024-2024)
Table 30. Global Human Rotavirus Vaccine Revenue by Company (2024-2024) & (US$ Million)
Table 31. Global Human Rotavirus Vaccine Revenue Share by Company (2024-2024)
Table 32. Global Market Human Rotavirus Vaccine Price by Company (2024-2024) & (USD/Unit)
Table 33. Global Human Rotavirus Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Human Rotavirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Rotavirus Vaccine as of 2022)
Table 36. Date of Key Manufacturers Enter into Human Rotavirus Vaccine Market
Table 37. Key Manufacturers Human Rotavirus Vaccine Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Human Rotavirus Vaccine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Global Human Rotavirus Vaccine Sales by Region (2024-2024) & (K Units)
Table 41. Global Human Rotavirus Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 42. Global Human Rotavirus Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 43. Global Human Rotavirus Vaccine Sales Market Share in Value by Region (2024-2024)
Table 44. Global Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 45. Global Human Rotavirus Vaccine Sales by Region (2024-2034) & (K Units)
Table 46. Global Human Rotavirus Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Human Rotavirus Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Human Rotavirus Vaccine Sales Market Share in Value by Region (2024-2034)
Table 49. Global Human Rotavirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 50. Global Human Rotavirus Vaccine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 51. Global Human Rotavirus Vaccine Sales by Application (2024-2024) & (K Units)
Table 52. Global Human Rotavirus Vaccine Sales Market Share in Volume by Application (2024-2024)
Table 53. Global Human Rotavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 54. Global Human Rotavirus Vaccine Sales Market Share in Value by Application (2024-2024)
Table 55. Global Human Rotavirus Vaccine Price by Application (2024-2024) & (USD/Unit)
Table 56. Global Human Rotavirus Vaccine Sales by Application (2024-2034) & (K Units)
Table 57. Global Human Rotavirus Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Human Rotavirus Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Human Rotavirus Vaccine Sales Market Share in Value by Application (2024-2034)
Table 60. Global Human Rotavirus Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 61. North America Human Rotavirus Vaccine Sales by Application (2024-2024) (K Units)
Table 62. North America Human Rotavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 63. Europe Human Rotavirus Vaccine Sales by Application (2024-2024) (K Units)
Table 64. Europe Human Rotavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 65. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2024-2024) (K Units)
Table 66. Asia-Pacific Human Rotavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 67. Latin America Human Rotavirus Vaccine Sales by Application (2024-2024) (K Units)
Table 68. Latin America Human Rotavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 69. Middle East and Africa Human Rotavirus Vaccine Sales by Application (2024-2024) (K Units)
Table 70. Middle East and Africa Human Rotavirus Vaccine Sales by Application (2024-2024) & (US$ Million)
Table 71. North America Human Rotavirus Vaccine Sales by Country (2024-2024) & (K Units)
Table 72. North America Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 73. North America Human Rotavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 74. North America Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 75. North America Human Rotavirus Vaccine Sales by Country (2024-2034) & (K Units)
Table 76. North America Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Human Rotavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Human Rotavirus Vaccine Sales by Country (2024-2024) & (K Units)
Table 80. Europe Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 81. Europe Human Rotavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 82. Europe Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 83. Europe Human Rotavirus Vaccine Sales by Country (2024-2034) & (K Units)
Table 84. Europe Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Human Rotavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2024-2024) & (K Units)
Table 88. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Volume by Region (2024-2024)
Table 89. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Value by Region (2024-2024)
Table 91. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Human Rotavirus Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Human Rotavirus Vaccine Sales by Country (2024-2024) & (K Units)
Table 96. Latin America Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 97. Latin America Human Rotavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 98. Latin America Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 99. Latin America Human Rotavirus Vaccine Sales by Country (2024-2034) & (K Units)
Table 100. Latin America Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Human Rotavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2024-2024) & (K Units)
Table 104. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2024)
Table 105. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2024-2024) & (US$ Million)
Table 106. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2024)
Table 107. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Human Rotavirus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 111. Bharat Biotech Company Information
Table 112. Bharat Biotech Introduction and Business Overview
Table 113. Bharat Biotech Human Rotavirus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 114. Bharat Biotech Human Rotavirus Vaccine Product
Table 115. Bharat Biotech Recent Development
Table 116. Merck Company Information
Table 117. Merck Introduction and Business Overview
Table 118. Merck Human Rotavirus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 119. Merck Human Rotavirus Vaccine Product
Table 120. Merck Recent Development
Table 121. GlaxoSmithKline Company Information
Table 122. GlaxoSmithKline Introduction and Business Overview
Table 123. GlaxoSmithKline Human Rotavirus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 124. GlaxoSmithKline Human Rotavirus Vaccine Product
Table 125. GlaxoSmithKline Recent Development
Table 126. Key Raw Materials Lists
Table 127. Raw Materials Key Suppliers Lists
Table 128. Human Rotavirus Vaccine Market Trends
Table 129. Human Rotavirus Vaccine Market Drivers
Table 130. Human Rotavirus Vaccine Market Challenges
Table 131. Human Rotavirus Vaccine Market Restraints
Table 132. Human Rotavirus Vaccine Distributors List
Table 133. Human Rotavirus Vaccine Downstream Customers
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Rotavirus Vaccine Product Picture
Figure 2. Global Human Rotavirus Vaccine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Rotavirus Vaccine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Human Rotavirus Vaccine Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Rotarix
Figure 6. Global Rotarix Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of RotaTeq
Figure 8. Global RotaTeq Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Rotavac
Figure 10. Global Rotavac Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Rotavin-M1
Figure 12. Global Rotavin-M1 Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Lanzhou lamb
Figure 14. Global Lanzhou lamb Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Global Human Rotavirus Vaccine Sales by Type (2024-2034) & (US$ Million)
Figure 18. Global Human Rotavirus Vaccine Sales Market Share by Type in 2022 & 2034
Figure 19. North America Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. North America Human Rotavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Europe Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Europe Human Rotavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 25. Latin America Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Human Rotavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Rotavirus Vaccine Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Rotavirus Vaccine Revenue in 2022
Figure 31. Human Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 32. Product Picture of Hospitals & Clinics
Figure 33. Global Hospitals & Clinics Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Academic And Research
Figure 35. Global Academic And Research Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Global Human Rotavirus Vaccine Sales by Application (2024-2034) & (US$ Million)
Figure 39. Global Human Rotavirus Vaccine Sales Market Share by Application in 2022 & 2034
Figure 40. North America Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. North America Human Rotavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Europe Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Europe Human Rotavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Human Rotavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 46. Latin America Human Rotavirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Human Rotavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Human Rotavirus Vaccine Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Human Rotavirus Vaccine Manufacturing Cost Structure
Figure 51. Human Rotavirus Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed